Unibio Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
151
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$758K
- Investors
-
7
Unibio General Information
Description
Provider of a bioindustrial platform intended to produce sustainable protein at an industrial scale and address global food security challenges. The company offers a patented Vertical Loop Bioreactor that converts methane into protein through efficient, modular, and climate-independent fermentation, enabling food producers and agribusinesses to reduce environmental impact, conserve resources, and ensure a resilient and scalable food supply.
Contact Information
Website
www.unibio.dkCorporate Office
- Langebjerg 1
- 4000 Roskilde
- Denmark
Corporate Office
- Langebjerg 1
- 4000 Roskilde
- Denmark
Unibio Timeline
Unibio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 01-Jun-2024 | $758K | Completed | Generating Revenue | ||
| 13. Later Stage VC | 05-Jul-2023 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 23-Dec-2022 | Completed | Generating Revenue | |||
| 11. Debt - General | 01-Jun-2021 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 23-Dec-2019 | Completed | Generating Revenue | |||
| 9. Corporate | 04-Dec-2019 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jan-2016 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 10-Jun-2015 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 09-Oct-2014 | $793K | $3.01M | Completed | Generating Revenue | |
| 5. Grant | 01-Jan-2014 | $2.21M | Completed | Generating Revenue |
Unibio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 82,600 | $3.3 | $3.3 | 1x | $3.3 | 1.22% | ||
| Ordinary | 55,500 | $1.27 | $1.27 | 1x | $1.27 | 0.82% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Unibio Comparisons
Industry
Financing
Details
Unibio Competitors (3)
One of Unibio’s 3 competitors is Calysta, a Venture Capital-Backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Calysta | Venture Capital-Backed | San Mateo, CA | ||||
| Knip (Commercial Products) | Venture Capital-Backed | Boston, MA | ||||
| Arbiom | Venture Capital-Backed | Paris, France |
Unibio Patents
Unibio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026229544-A1 | A fermentor and method of performing a fermentation process | Pending | 30-Apr-2025 | ||
| WO-2026229545-A1 | A fermentor and method of performing a fermentation process | Pending | 30-Apr-2025 | ||
| WO-2025116037-A1 | Modified p4hb | Inactive | 01-Dec-2023 | ||
| AU-2024373981-A1 | A fermentor and method of performing a fermentation process | Pending | 31-Oct-2023 | ||
| EP-4802043-A1 | A fermentor and method of performing a fermentation process | Pending | 31-Oct-2023 | C12M29/18 |
Unibio Signals
Unibio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Double Bioventures | Venture Capital | Minority | ||
| ICP Group (Denmark) | Venture Capital | Minority | ||
| Saudi Industrial Investment Group | Holding Company | Minority | ||
| Wealth Club | Corporation | Minority | ||
| Mitsubishi | Corporation | Minority |
Unibio Investments (5)
Unibio’s most recent deal was a Joint Venture with Single-Cell Protein Plant (Saudi Industrial Investment Group / Unibio International) for . The deal was made on 16-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Single-Cell Protein Plant (Saudi Industrial Investment Group / Unibio International) | 16-Mar-2026 | Joint Venture | Food Products | ||
| Arrow Therapeutics | 01-Dec-2003 | Early Stage VC | Drug Discovery | ||
| Inpharmatica | 03-Jul-2001 | Early Stage VC | Discovery Tools (Healthcare) | ||
| Arrow Therapeutics | 06-Jul-2000 | Early Stage VC | Drug Discovery | ||
| Arrow Therapeutics | 01-Jan-1999 | Seed Round | Drug Discovery |
Unibio FAQs
-
When was Unibio founded?
Unibio was founded in 2001.
-
Where is Unibio headquartered?
Unibio is headquartered in Roskilde, Denmark.
-
What is the size of Unibio?
Unibio has 151 total employees.
-
What industry is Unibio in?
Unibio’s primary industry is Biotechnology.
-
Is Unibio a private or public company?
Unibio is a Private company.
-
What is Unibio’s current revenue?
The current revenue for Unibio is .
-
How much funding has Unibio raised over time?
Unibio has raised $123M.
-
Who are Unibio’s investors?
Double Bioventures, ICP Group (Denmark), Saudi Industrial Investment Group, Wealth Club, and Mitsubishi are 5 of 7 investors who have invested in Unibio.
-
Who are Unibio’s competitors?
Calysta, Knip (Commercial Products), and Arbiom are competitors of Unibio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process